Interrelationships of factor VII activity and plasma leptin with insulin resistance in coronary heart disease

Atherosclerosis

Volumn 209, Issue 1, 2010, Pages 235-240

  Karatela, Rubina A ^a   Sainani, Gurmukh S ^a  

^a JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

Coronary heart disease; Factor VII activity levels; Insulin resistance; Plasma leptin

Indexed keywords

BLOOD CLOTTING FACTOR 7; FIBRINOGEN; LEPTIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

ADULT; CORONARY DISEASE; FACTOR VII; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED;

EID: 77049115183     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.08.043     Document Type: Article

References (30)

1. DeWood M., Spores J., Notske R., et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303 (1980) 897-902
2. Meade T.W., Mellows S., Brozovic M., et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 2 (1986) 533-537
3. Suzuki T., Yamauchi K., Matsushita T., et al. Elevation of factor VII activity and mass in coronary artery disease of varying severity. Clin Cardiol 14 (1991) 731-736
4. Broadhurst P., Kelleher C., Hughes L., Imeson J.D., and Raftery E.B. Fibrinogen, factor VII clotting activity and coronary artery disease severity. Atherosclerosis 85 (1990) 169-173
5. Hoffman C.J., Miller R.H., Lawson W.E., and Hultin M.B. Elevation of factor VII activity and mass in young adults at risk of ischemic heart disease. J Am Coll Cardiol 14 (1989) 941-946
6. Wu K.K., Folsom A.R., Heiss G., et al. Association of coagulation factors and inhibitors with carotid artery atherosclerosis: early results of the ARIC study. Ann Epidemiol 2 (1992) 471-480
7. Folsom A.R., Wu K.K., Rosamond W.D., Sharrett A.R., and Chambless L.E. A prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 96 (1997) 1102-1108
8. Heinrich J., Balleisen L., Schulte H., Assmann G., and van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arterioscler Thromb 14 (1994) 54-59
9. Folsom A.R., Wu K.K., Davis C.E., et al. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 91 (1991) 191-205
10. Reaven G.M. The role of insulin resistance and hyperinsulinemia in coronary heart disease. Metabolism 41 Suppl. 1 (1992) 16-19
11. Kamohara S., Burcelin R., Halaas J.L., Friedman J.M., and Charron M.J. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389 (1997) 374-377
12. Mantzoros C.S. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 130 (1999) 671-680
13. Soderberg S., Ahren B., Jansson J.H., et al. Leptin is associated with increased risk of myocardial infarction. J Intern Med 246 (1999) 409-418
14. Wallace A.M., McMahon A.D., Packard C.J., et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104 (2001) 3052-3056
15. DeFronzo R.A., and Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14 (1991) 173-194
16. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 7 (1985) 412-419
17. Mertens I., and Gaal F.V. Obesity, haemostasis and the fibrinolytic system. Obes Rev 3 (2002) 85-101
18. Lowe G.D.O., Rumley A., and Wannamethee S.G. Hemostatic abnormalities associated with obesity and the metabolic syndrome. J Thromb Haemost 3 (2005) 1076-1078
19. Wannamethee S.G., Lowe G.D., Shaper A.G., et al. The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men. Atherosclerosis 181 1 (2005) 101-108
20. Segal K.R., Landt M., and Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 45 (1996) 988-991
21. Donahue R.P., Zimmet P., Bean J.A., et al. Cigarette smoking, alcohol use, and physical activity in relation to serum leptin levels in a multiethnic population: The Miami Community Health Study. Ann Epidemiol 9 2 (1999) 108-113
22. Kieffer T.J., Heller R.S., and Habaner J.F. Leptin receptors expressed on pancreatic b-cells. Biochem Biophys Res Commun 224 (1996) 522-527
23. Margetic S., Gazzola C., Pegg C.G., and Hill R.A. Leptin: a review of its peripheral actions and interactions. Int J Obes 26 (2002) 1407-1433
24. Wannamethee S.G., Tchernova J., Whincup P., et al. Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis 191 2 (2007) 418-426
25. Kain K., Catto A.J., and Grant P.J. Associations between insulin resistance and thrombotic risk factors in high-risk South Asian subjects. Diabet Med 20 8 (2003) 651-655
26. Godsland I.F., Crook D., Proudler A.J., and Stevenson J.C. Hemostatic risk factors and insulin sensitivity, regional body fat distribution, and the metabolic syndrome. J Clin Endocrinol Metab 90 1 (2005) 190-197
27. Romano M., Guagnano M.T., Pacini G., et al. Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. J Clin Endocrinol Metab 88 11 (2003) 5321-5326
28. Cooke J.P., and Oka R.K. Does leptin cause vascular disease?. Circulation 106 15 (2002) 1904-1905
29. Juhan-Vague I., Alessi M.C., Mavri A., et al. Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J Thromb Haemost 1 (2003) 1575-1579
30. Toschi V., Gallo R., Lettino M., et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 95 3 (1997) 594-599